ATE42895T1 - Steroide als immunomodulierende mittel. - Google Patents

Steroide als immunomodulierende mittel.

Info

Publication number
ATE42895T1
ATE42895T1 AT85200423T AT85200423T ATE42895T1 AT E42895 T1 ATE42895 T1 AT E42895T1 AT 85200423 T AT85200423 T AT 85200423T AT 85200423 T AT85200423 T AT 85200423T AT E42895 T1 ATE42895 T1 AT E42895T1
Authority
AT
Austria
Prior art keywords
sup
steroids
substituent
immunomodulating agents
oxy
Prior art date
Application number
AT85200423T
Other languages
English (en)
Inventor
Jan Kelder
Hermanus Antonius Mari Verheul
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE42895T1 publication Critical patent/ATE42895T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85200423T 1984-03-21 1985-03-20 Steroide als immunomodulierende mittel. ATE42895T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8400888 1984-03-21
EP85200423A EP0159739B1 (de) 1984-03-21 1985-03-20 Steroide als immunomodulierende Mittel

Publications (1)

Publication Number Publication Date
ATE42895T1 true ATE42895T1 (de) 1989-05-15

Family

ID=19843679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85200423T ATE42895T1 (de) 1984-03-21 1985-03-20 Steroide als immunomodulierende mittel.

Country Status (6)

Country Link
US (1) US4701450A (de)
EP (1) EP0159739B1 (de)
JP (1) JPS60209599A (de)
AT (1) ATE42895T1 (de)
DE (1) DE3570038D1 (de)
MX (1) MX9203811A (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222385B1 (de) * 1985-11-13 1993-02-03 Research Development Corporation of Japan Geschlechtshormone zur Behandlung von Immun-Mangel-Krankheiten
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4902681A (en) * 1987-08-27 1990-02-20 University Of Pennsylvania Inhibition of immune clearance using progesterone analogues
US4908358A (en) * 1987-08-27 1990-03-13 Trustees Of The University Of Pennsylvania Inhibition of immune clearance using progesterone analogues
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
US5201280A (en) * 1989-06-06 1993-04-13 Reproductive Sciences, Inc. Method for preferential production of female turtles, lizards, and crocodiles
JP2683783B2 (ja) * 1992-07-10 1997-12-03 雪印乳業株式会社 シェーグレン症候群治療剤
US5639743A (en) * 1992-11-13 1997-06-17 University Of Georgia Research Foundation Compositions and methods for treating exocrine gland atrophy
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
WO1994022451A1 (en) * 1993-04-07 1994-10-13 Oklahoma Medical Research Foundation Selective regulation of b lymphocyte precursors by hormones
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
SK284569B6 (sk) * 1998-10-16 2005-06-02 Akzo Nobel N.V. Vysoko čistá zlúčenina (7alfa, 17alfa)-17-hydroxy-7-metyl-19-nor- 17-pregn-5(10)-én-20-ín-3-ón, spôsob jej prípravy a farmaceutická dávková jednotka s jej obsahom
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US7371385B2 (en) 2000-05-12 2008-05-13 Oregon Health & Science University Method of treating immune pathologies with low dose estrogen
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
ATE364619T1 (de) * 2001-10-18 2007-07-15 Norton Healthcare Ltd Tibolonformulierungen
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
AU2004203420B8 (en) * 2003-05-23 2008-02-21 N.V. Organon Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
WO2005120517A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
US8053197B2 (en) 2004-07-30 2011-11-08 Oregon Health & Science University Methods for detecting and treating autoimmune disorders
US8175031B2 (en) 2004-11-18 2012-05-08 Telefonaktiebolaget Lm Ericsson (Publ) Method and apparatus for supporting packet data services in service area boundary regions
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
WO2017191266A1 (en) * 2016-05-04 2017-11-09 Mithra Pharmaceuticals S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB885782A (en) * 1958-01-24 1961-12-28 Searle & Co Improvements in or relating to androstenone and androstanone derivatives
GB884412A (en) * 1958-09-20 1961-12-13 Organon Labor Ltd New 6-methyl-19-nor-steroids and process for the preparation thereof
US3012045A (en) * 1959-01-22 1961-12-05 Searle & Co 17alpha-alkenyl derivatives of 6alpha-methyl-17beta-hydroxy-19-nor-4-androsten-3-one
BE593958A (nl) * 1959-08-17 1960-12-01 Organon Nv Werkwijze ter bereidung van op plaats 3 niet geoxygeneerde 19-nor-steroiden
GB941634A (en) * 1960-11-16 1963-11-13 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
BE640298A (de) * 1962-11-23
BE665514A (de) * 1964-06-16
BE665515A (de) * 1964-06-17
US3515719A (en) * 1967-03-15 1970-06-02 Upjohn Co 7-methyl-6,19-epoxy steroids of the androstane series
NL6901532A (de) * 1969-01-30 1970-08-03
US4412993A (en) * 1980-01-25 1983-11-01 The Upjohn Company Method of treating pseudopregnancy, galactorrhea and mastitis in mammals
US4546098A (en) * 1984-04-13 1985-10-08 The Rockefeller University Estrogen synthesis inhibitors

Also Published As

Publication number Publication date
DE3570038D1 (en) 1989-06-15
US4701450A (en) 1987-10-20
EP0159739B1 (de) 1989-05-10
EP0159739A1 (de) 1985-10-30
MX9203811A (es) 1992-07-01
JPS60209599A (ja) 1985-10-22

Similar Documents

Publication Publication Date Title
DE3570038D1 (en) Steroids for use as immunomodulators
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
BRPI9909908B8 (pt) conjugados de ácido graxo de sal ou ácido biliar, composição farmacêutica compreendendo os mesmos e seus usos
DE68917884D1 (de) Phosphinsäure-Derivate von Steroiden als 5-alpha-Reduktase-Inhibitoren.
DK73594A (da) Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ES2130452T3 (es) Derivados de ciclobutano utilizados como inhibidores de la escualeno-sintetasa y de la farnesiltransferasa proteica.
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
FI874189L (fi) Epimeerisen jakaantumisen säätelymenetelmä pregnaanijohdannaisten 16,17-asetaalien valmistuksessa
DE3860201D1 (de) Entzuendungshemmende agentien.
NZ222399A (en) Cephalosporin derivatives; pharmaceutical compositions and processes for preparation
DK282784A (da) 1-alkyl-androsta-1,4-dien-3,17-dioner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
ATE110736T1 (de) Phosphonsäure-derivate von steroiden als hemmstoffe der 5-alpha-reduktase.
ATE90355T1 (de) Weiche steroide mit anti-entzuendungswirkung.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
FR2361879A2 (fr) Nouvelles 4,5,6,7- tetrahydro-7-oxo (ou hydroxy)benzo (b)thienyl-4-amines utiles notamment comme agents de croissance pour animaux et leur procede de preparation
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
FI873574A0 (fi) Platinaderivat.
FR2422638A1 (fr) Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires
UA29395C2 (uk) Похідне прегна-4,9(11),17(20)-трієн-3-она, спосіб його одержання, спосіб одержання 21-ацилоксипрегна-4, 9(11),16-трієн-3,20-діону та проміжні сполуки
FR2397427A1 (fr) Derives de steroide et leur procede de preparation
ES2179206T3 (es) Derivados de 12h-dibenzo(d,g)(1,3)dioxocina.
SE8506015D0 (sv) Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
DK515486D0 (da) 1-methyl-15alfa-alkyl-androsta-1,4-dien-3,17-dioner, fremgangsmaade tilfremstilling deraf og farmaceutiske praeparater der indeholder disse
ATE173467T1 (de) Hexahydrobenzo(f)quinolinone als 5-alpha- reduktase inhibitoren

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee